5 completed, 2 recruiting, 1 terminated, 1 unknown. 10 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Completed 5, Recruiting 2, Terminated 1, Unknown 1, Withdrawn 1 |
Follow SSRI: new trials by email Literature Review of SSRI trials Research Report on SSRI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder Virtual Reality Exposure Therapy, Sertraline (Oral Antidepressant) - Social Anxiety Disorder | Phase 4 | Recruiting | Emine Kanmaz | 56 | 2024-11-15 | 2025-09-25 |
| Detoxification From the Lipid Tract electroencephalogram biofeedback, electrical brain stimulation, ultra-low frequency transcranial magnetic stimulation - COVID-19 Vaccine Adverse Reaction | Phase 4 | Completed | Pachankis, Yang I., M.D. | 1 | 2024-02-26 | 2024-04-10 |
| Non-invasive BCI and Application Verification for Depressed People SSRI, rTMS, Neuro-Feedback - Depression, Major Depressive Disorder | Phase 4 | Recruiting | Shanghai Mental Health Center | 400 | 2023-07-01 | 2024-05-16 |
| A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women Sertraline, Interpersonal therapy - Perinatal Depression, HIV-1-infection | Phase 4 | Completed | University of North Carolina, Chapel Hill | 80 | 2019-10-30 | 2021-11-10 |
| The ISLAND Study: InSuLa Assessed Needs for Depression Selective serotonin re-uptake inhibitor, Cognitive Behavioral Therapy, Combination treatment (SSRI + CBT) - Depression | Phase 4 | Completed | Emory University | 77 | 2014-09-01 | 2020-11-05 |
| Trial of Sertraline Versus Cognitive Behaviour Therapy for Generalised Anxiety Sertraline, Cognitive Behavioural Therapy - Generalised Anxiety Disorder | Phase 4 | Terminated | University College, London | 5 | 2014-08-01 | 2016-07-11 |
| Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment SSRI, CBT - Internalizing Psychopathologies (IPs) Depression and Anxiety | Phase 4 | Completed | University of Illinois at Chicago | 271 | 2013-12-13 | 2018-10-11 |
| The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope SSRI monotherapy, Seroquel XR adjunctive - Major Depressive Disorder | Phase 4 | Unknown | Inje University | 60 | 2011-05-01 | 2012-11-01 |
| Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients Effexor, SSRI - Major Depressive Disorder | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 1151 | 2007-04-01 | 2012-03-05 |
| Escitalopram Treatment In Acute Stroke Escitalopram, Placebo - Stroke | Phase 4 | Withdrawn | University of Aarhus | 2012-06-19 |
Depression (4) · Depressive Disorder, Major (4) · Anxiety Disorders (2) · Bipolar Disorder (1) · Generalized Anxiety Disorder (1) · Ichthyosis prematurity syndrome (1) · Phobia, Social (1) · Stroke (1)
Emine Kanmaz (1) · Emory University (1) · Inje University (1) · Pachankis, Yang I., M.D. (1) · Shanghai Mental Health Center (1) · University College, London (1) · University of Aarhus (1) · University of Illinois at Chicago (1) · University of North Carolina, Chapel Hill (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
China (3) · United States (2) · Denmark (1) · South Korea (1) · Turkey (Türkiye) (1) · United Kingdom (1) · Zambia (1)
Boadie W Dunlop, MD/MS (1) · Elizabeth Stringer, MD (1) · Grethe Andersen, Prof. DMSc (1) · K. Luan Phan, MD (1) · Marta Buszewicz (1) · Seung-Hwan Lee, MD, PhD (1) · Zhenghui Yi, chief physician (1)
PMID 29894598, PMID 31060042, PMID 33896622, PMID 34274600, PMID 35803896, PMID 42286600
R01MH073719 (1), R01MH101497 (1), R21MH115806 (1)